Loading chat...
NJ A5488
Bill
Status
Introduced
5/18/2023
Primary Sponsor
Kevin Rooney
Click for details
AI Summary
Legislative Description
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.
Judiciary
Last Action
Introduced, Referred to Assembly Judiciary Committee
5/18/2023
Committee Referrals
Judiciary5/18/2023
Full Bill Text
No bill text available